Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revisionBoth sides next revision
home:diseases:hypercalcemia [02.18.2019] – [Hypercalcemia (hypercalcaemia)] sallieqhome:diseases:hypercalcemia [02.18.2019] – [Hypercalcemia (hypercalcaemia)] sallieq
Line 11: Line 11:
  
 Hypercalcaemia - presentation and management  (({{pubmed>long:28572230}})) Hypercalcaemia - presentation and management  (({{pubmed>long:28572230}}))
-<blockquote>Hypercalcaemia is a common disorder normally caused by primary hyperparathyroidism (PHPT) or malignancy. A proportion of cases present as an emergency, which carries a significant mortality. Emergency management of hypercalcaemia is based on intravenous rehydration with normal saline but when this is inadequate, bisphosphonate therapy is used; more recently the novel anti-resorbtive agent denosumab has been shown to have a useful role in treatment. It is estimated that up to 10% of all cases of PHPT presenting under the age of 45 years have an underlying genetic predisposition; nine potentially causative genes are now recognised and may be screened in routine clinical practice. Although parathyroidectomy is the only curative treatment for PHPT, this is indicated in a minority of cases. +<blockquote>Hypercalcaemia is a common disorder normally caused by primary hyperparathyroidism (PHPT) or malignancy. A proportion of cases present as an emergency, which carries a significant mortality. Emergency management of hypercalcaemia is based on intravenous rehydration with normal saline but when this is inadequate, bisphosphonate therapy is used; more recently the novel anti-resorbtive agent denosumab has been shown to have a useful role in treatment.  
 + 
 +Although parathyroidectomy is the only curative treatment for PHPT, this is indicated in a minority of cases. 
 </blockquote> </blockquote>
  
home/diseases/hypercalcemia.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.